WELCOME TO THE ADD-ASPIRIN WEBSITE

This website is designed to provide information about the Add-Aspirin Trial, both for people taking part in the trial (participants) and collaborators. Please use the menus at the top of the screen to find out more about the trial.           

Add-Aspirin is a large randomised clinical trial, which is taking place in the UK and India. It will recruit 11,000 participants to help find out whether regular aspirin use after treatment for an early stage cancer can prevent the cancer from coming back and preventing deaths.

Congratulations to our top 5 recruiting centres:
1. Royal Marsden Hospitals
2. Worcestershire Royal Hospital
3. University Hospitals Coventry & Warwickshire
4. Bristol Haematology & Oncology Centre
5. Royal Lancaster Infirmary


*FOR GENERAL AND CLINICAL QUERIES, PLEASE CHECK OUR
FAQs*

NEWS

December 2016

Christmas & New Year Opening Times


Add-Aspirin Randomisation will be closed 23rd December - 2nd Jan and will reopen at 9am on 3rd January 2017. There will be limited MRC CTU cover between 28th - 30th December.

Last date for sending translational samples to biobanks: 21st December 2016.


Read more

Quick links for
NHS professionals


REGISTER A PARTICIPANT

To RANDOMISE a participant please call +44 (0)20 7670 4777

UNBLIND A PARTICIPANT

 

BREAST


We aim to recruit 3100 individuals who have had surgery to remove an early stage breast cancer. 

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here   

Top recruiters: Royal Marsden Hospital, Western General Hospital, Great Western Hospital, Royal Cornwall Hospital

PARTICIPANTS REGISTERED: 885
PARTICIPANTS RANDOMISED: 620
   

COLON/RECTUM 


We aim to to recruit 2600 individuals who have had surgery to remove an early stage bowel cancer. 

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here 

Top recruiters: Bristol Haematology & Oncology Centre, Darlington Hospital, Royal Marsden Hospitals

PARTICIPANTS REGISTERED: 477
PARTICIPANTS RANDOMISED: 333

STOMACH/OESOPHAGUS 


We aim to recruit 2100 individuals who have had surgery or a combination of chemotherapy and radiotherapy to treat a cancer of the stomach or oesophagus (food pipe).

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here

Top recruiters: Leicester Royal Infirmary, St James's Leeds, The Christie, UHCW

PARTICIPANTS REGISTERED: 60
PARTICIPANTS RANDOMISED: 46

PROSTATE


We aim to recruit 2120 individuals who have had surgery or radiotherapy to treat an early stage prostate cancer. 

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here    

Top recruiters: Bristol Haematology & Oncology Centre, UCHW, University Hospital of Wales
                                             PARTICIPANTS REGISTERED: 386
PARTICIPANTS RANDOMISED: 271
     

The trial is being jointly funded by Cancer Research UK (grant number C471 /A15015, www.cancerresearchuk.org), the National Institute for Health Research Health Technology Assessment Programme (project number 12/01/38, www.nihr.ac.uk) and the MRC Clinical Trials Unit at UCL.
© Add-Aspirin, MRC CTU at UCL